Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Farouc Jaffer
Massachusetts General Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Boston Scientific Corporation
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Jaffer receives consulting income from Boston Scientific Corporation, which makes drug eluting stents (DES) that are used in the study. The research project develops new technology to image plaques and coronary stents in order to determine how plaque inflammation modulates atheroma progression and stent restenosis and how plaque inflammation modulates stent healing and risk of stent thrombosis. The research project also investigates the biological healing profiles of the newest generation of DES introduced into clinical practice as compared to current generation DES and, in doing so, specifically investigates Boston Scientific’s stents. The results of these studies could therefore be of interest to the company. The Partners Committee on Outside Activities review panel evaluated the financial interest in connection with this research project and determined that, based on the close connection between the company’s interests and the research, the financial interest could directly and significantly affect the design, conduct, or reporting of the research.
NIRF-OFDI of Inflammation in Atheroma Progression and Stent Complications
This proposal will develop new technology to image plaques and coronary stents that could cause heart attacks and death. We will image inflamed plaques and stents in living subjects that may progress, scar and clot. This information will help better guide current and new therapies to prevent heart attacks and death.
Filed on April 06, 2018.
Tell us what you know about Farouc Jaffer's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Farouc Jaffer filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Farouc Jaffer | Massachusetts General Hospital | Conflict of Interest | Abbott Laboratories | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.